Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross L Cagan

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
Pageof 6